GlaxoSmithKline (nyse: GSK - news - people ) already announced a similar effort to put up a clinical trial registry, after New York State Attorney General Eliot Spitzer filed a lawsuit relating to unpublished data on Glaxo's antidepressant Paxil.
FORBES: Silver Lining In Drug Disclosure